MicroRNAs and their targets from <Emphasis Type="Italic">Arabidopsis</Emphasis> to rice: half conserved and half diverged

MicroRNAs are 21-to 24-nucleotide long, endogenous non-coding RNAs in eukaryotes (Hannon, 2002). Mature microRNAs generated by Dicer are incorporated into an RNA-induced silencing complex (RISC), resulting in gene silencing via the cleavage of a target mRNA or the repression of target mRNA translation (Qi et al, 2005).     

The First Symposium on Frontiers of Biomedical Sciences Organizedby Cell Research, on "Epigenetics in Development and Diseases "Hope Hotel, Shanghai, China, Oct. 24-26, 2003

addresses the inheritable phenomena that are non-attributable to the sequence changes in genome and the players as well as the underlying mechanisms that are operated at the levels of DNA methylation, histone modification, chromatin remolding and gene expression. Epigenetic mechanisms in all biological processes match its genetic counterparts in significance. Both establishment and maintenance of the DNA methylation profiles of the higher eukaryotes are under the precise controls, the details and key players of which remain largely unknown.     

MicroRNAs,stem cells and cancer stem cells

This review discusses the various regulatory charac-teristics of microRNAs that are capable of generating widespread changes in gene expression via post translational repression of many mRNA targets and control self-renewal, differentiation and division of cells. It controls the stem cell functions by controlling a wide range of pathological and physiological processes, including development, differentiation, cellular proliferation, programmed cell death, oncogenesis and metastasis. Through either mRNA cleavage or translational repression, miRNAs alter the expression of their cognate target genes; thereby modulating cellular pathways that affect the normal functions of stem cells, turning them into cancer stem cells, a likely cause of relapse in cancer patients. This present review further emphasizes the recent discoveries on the functional analysis of miRNAs in cancer metastasis and implications on miRNA based therapy using miRNA replacement or anti-miRNA technologies in specific cancer stem cells that are required to establish their efficacy in controlling tumorigenic potential and safe therapeutics.     

mRNA出核转运及其偶联网络

真核细胞中,编码蛋白质基因的表达是一个复杂的、分步骤进行的过程,这个过程从转录和新生pre-mRNA的核内加工开始,经过正确加工的成熟mRNA从加工位点释放,出核转运后在细胞质内翻译成蛋白质。mRNA出核转运是基因表达中的关键步骤,由进化上高度保守的特定蛋白质介导完成。mRNA出核与转录和mRNA加工步骤密切偶联,这样的偶联可以提高基因表达的有效性和准确性。     

Slowing Bacterial Translation Speed Enhances Eukaryotic Protein Folding Efficiency

The mechanisms for de novo protein folding differ significantly between bacteria and eukaryotes, as evidenced by the often observed poor yields of native eukaryotic proteins upon recombinant production in bacterial systems. Polypeptide synthesis rates are faster in bacteria than in eukaryotes, but the effects of general variations in translation rates on protein folding efficiency have remained largely unexplored. By employing Escherichia coli cells with mutant ribosomes whose translation speed can be modulated, we show here that reducing polypeptide elongation rates leads to enhanced folding of diverse proteins of eukaryotic origin. These results suggest that in eukaryotes, protein folding necessitates slow translation rates. In contrast, folding in bacteria appears to be uncoupled from protein synthesis, explaining our findings that a generalized reduction in translation speed does not adversely impact the folding of the endogenous bacterial proteome. Utilization of this strategy has allowed the production of a native eukaryotic multidomain protein that has been previously unattainable in bacterial systems and may constitute a general alternative to the production of aggregation-prone recombinant proteins.     

Translation initiation: structures, mechanisms and evolution

Translation, the process of mRNA-encoded protein synthesis, requires a complex apparatus, composed of the ribosome, tRNAs and additional protein factors, including aminoacyl tRNA synthetases. The ribosome provides the platform for proper assembly of mRNA, tRNAs and protein factors and carries the peptidyl-transferase activity. It consists of small and large subunits. The ribosomes are ribonucleoprotein particles with a ribosomal RNA core, to which multiple ribosomal proteins are bound. The sequence and structure of ribosomal RNAs, tRNAs, some of the ribosomal proteins and some of the additional protein factors are conserved in all kingdoms, underlying the common origin of the translation apparatus. Translation can be subdivided into several steps: initiation, elongation, termination and recycling. Of these, initiation is the most complex and the most divergent among the different kingdoms of life. A great amount of new structural, biochemical and genetic information on translation initiation has been accumulated in recent years, which led to the realization that initiation also shows a great degree of conservation throughout evolution. In this review, we summarize the available structural and functional data on translation initiation in the context of evolution, drawing parallels between eubacteria, archaea, and eukaryotes. We will start with an overview of the ribosome structure and of translation in general, placing emphasis on factors and processes with relevance to initiation. The major steps in initiation and the factors involved will be described, followed by discussion of the structure and function of the individual initiation factors throughout evolution. We will conclude with a summary of the available information on the kinetic and thermodynamic aspects of translation initiation.     

The Mechanism of Eukaryotic Translation Initiation: New Insights and Challenges

Translation initiation in eukaryotes is a highly regulated and complex stage of gene expression. It requires the action of at least 12 initiation factors, many of which are known to be the targets of regulatory pathways. Here we review our current understanding of the molecular mechanics of eukaryotic translation initiation, focusing on recent breakthroughs from in vitro and in vivo studies. We also identify important unanswered questions that will require new ideas and techniques to solve.This work aims to present the current state of our knowledge of the molecular mechanics of translation initiation in eukaryotes. We focus on advances that have taken place over the last few years and, because of space limitations, assume readers will be able to find references to the foundational literature for the field (published before 2000) in the more recent works that are cited here. As always, we apologize for not having the space to cite many important works. Please view this as merely an introduction to the field rather than a complete summary.